In the five years since President Bush authorized and at the same time restricted research on human embryonic stem cells, a marked shift has taken place in some scientists� views of how the research is likely to benefit medicine. Many no longer see cell therapy as the first goal of the research, parting company with those whose near-term expectations for cell therapy remain high.
Office of Strategic Communication